Morgan B P
Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, U.K.
Biochem J. 1992 Mar 1;282 ( Pt 2)(Pt 2):409-13. doi: 10.1042/bj2820409.
Several groups have recently described the isolation of a 20 kDa membrane-attack-complex (MAC)-inhibiting protein, termed 'CD59 antigen', from human erythrocyte membranes. Antibodies raised against erythrocyte CD59 antigen detect antigen on the surface of many other cell types, and in some of these cells the antigen has been shown to have a molecular mass similar to that of the erythrocyte protein and to confer resistance to lysis by the MAC. A platelet-membrane form of CD59 antigen has been described and reported to be much larger than the erythrocyte protein. Here I report the isolation of CD59 antigen from platelet membranes and its molecular and functional characterization. The platelet protein is not significantly larger than the erythrocyte form and possesses similar MAC-inhibiting activity. Platelet CD59 antigen is anchored to the membrane via a glycosyl-phosphatidylinositol link, and consequently it is suggested that deficiency of this protein might be responsible for the increased thrombotic tendency observed in paroxysmal nocturnal haemoglobinuria.
最近有几个研究小组报道了从人红细胞膜中分离出一种20 kDa的膜攻击复合物(MAC)抑制蛋白,称为“CD59抗原”。针对红细胞CD59抗原产生的抗体可检测许多其他细胞类型表面的抗原,并且在其中一些细胞中,该抗原已被证明具有与红细胞蛋白相似的分子量,并能赋予细胞对MAC介导的裂解的抗性。已经描述了一种血小板膜形式的CD59抗原,据报道其比红细胞蛋白大得多。在此,我报告了从血小板膜中分离出CD59抗原及其分子和功能特征。血小板蛋白并不比红细胞形式的蛋白大很多,并且具有相似的MAC抑制活性。血小板CD59抗原通过糖基磷脂酰肌醇连接锚定在膜上,因此有人认为该蛋白的缺乏可能是阵发性夜间血红蛋白尿中观察到的血栓形成倾向增加的原因。